colgate-palmolive co. - CL
CL
Close Chg Chg %
85.38 -0.28 -0.33%
Closed Market
85.10
-0.28 (0.33%)
Volume: 5.59M
Last Updated:
Apr 2, 2026, 4:00 PM EDT
Company Overview: colgate-palmolive co. - CL
CL Key Data
| Open $85.19 | Day Range 84.43 - 85.37 |
| 52 Week Range 74.55 - 99.32 | Market Cap $68.24B |
| Shares Outstanding 801.55M | Public Float N/A |
| Beta 0.33 | Rev. Per Employee N/A |
| P/E Ratio 32.39 | EPS $2.63 |
| Yield 244.30% | Dividend $0.53 |
| EX-DIVIDEND DATE Apr 20, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 6.82M |
CL Performance
No Data Available
CL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
An error occurred while fetching the data.
SEC Filings for Colgate-palmolive Co. - CL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Colgate-palmolive Co. - CL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 26, 2026 | John Hazlin Chief Growth Officer | 24,422 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share | 2,371,376.20 |
| Feb 26, 2026 | Jennifer M. Daniels CLO and Secretary | 102,195 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2026 | Jennifer M. Daniels CLO and Secretary | 89,844 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share | 8,723,852.40 |
| Feb 26, 2026 | Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin | 34,710 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2026 | Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin | 21,629 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share | 2,100,175.90 |
| Feb 26, 2026 | Noel R. Wallace Chairman, President & CEO; Director | 430,173 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2026 | Noel R. Wallace Chairman, President & CEO; Director | 361,921 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share | 35,142,529.10 |
| Feb 26, 2026 | Gregory Malcolm EVP and Controller | 18,158 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2026 | Gregory Malcolm EVP and Controller | 15,898 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share | 1,543,695.80 |
| Feb 26, 2026 | Stanley J. Sutula Chief Financial Officer | 94,066 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2026 | Stanley J. Sutula Chief Financial Officer | 74,320 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share | 7,216,472.00 |
| Feb 26, 2026 | John Hazlin Chief Growth Officer | 30,539 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2026 | Sally Massey Chief Human Resources Officer | 30,590 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2026 | Sally Massey Chief Human Resources Officer | 22,384 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share | 2,173,486.40 |
| Feb 13, 2026 | John Hazlin Chief Growth Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Apr 4, 2025 | Brian O. Newman Director | 2,597 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share | 238,898.03 |
| Apr 4, 2025 | Lorrie M. Norrington Director | 36,002 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share | 3,311,823.98 |
| Apr 4, 2025 | John P. Bilbrey Director | 33,688 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share | 3,098,959.12 |